The liver plays a central role in maintaining whole body metabolic and energy homeostasis by consuming and producing glucose and fatty acids. Glucose and fatty acids compete for hepatic substrate oxidation with regulation ensuring glucose is oxidized preferentially. Increasing fatty acid oxidation is expected to decrease lipid storage in the liver and avoid lipid-induced insulin-resistance. To increase hepatic lipid oxidation in the presence of glucose, we previously engineered a synthetic glyoxylate shunt into human hepatocyte cultures and a mouse model and showed that this synthetic pathway increases free fatty acid b-oxidation and confers resistance to diet-induced obesity in the mouse model. Here we used ensemble modeling to decipher the effects of perturbations to the hepatic metabolic network on fatty acid oxidation and glucose uptake. Despite sampling of kinetic parameters using the most fundamental elementary reaction models, the models based on current metabolic regulation did not readily describe the phenotype generated by glyoxylate shunt expression. Although not conclusive, this initial negative result prompted us to probe unknown regulations, and malate was identified as inhibitor of hexokinase 2 expression either through direct or indirect actions. This regulation allows the explanation of observed phenotypes (increased fatty acid degradation and decreased glucose consumption). Moreover, the result is a function of pyruvate-carboxylase, mitochondrial pyruvate transporter, citrate transporter protein, and citrate synthase activities. Some subsets of these flux ratios predict increases in fatty acid and decreases in glucose uptake after glyoxylate expression, whereas others predict no change. Altogether, this work defines the possible biochemical space where the synthetic shunt will produce the desired phenotype and demonstrates the efficacy of ensemble modeling for synthetic pathway design.
INTRODUCTION
Obesity is a global health concern of escalating proportions (1, 2) and is ultimately caused by an energy imbalance. Obesity is typically associated with elevated levels of plasma free fatty acids and triglycerides (3), a result of both excessive intake and de novo synthesis. This often leads to fatty acid storage in peripheral tissues such as the liver which results in the comorbidities associated with the metabolic syndrome including cardiovascular disease and insulin resistance (4) (5) (6) (7) . This suggests that increasing hepatic free fatty acid oxidation may improve the metabolic profile of obese patients.
Fatty acid oxidation is regulated such that glucose is oxidized preferentially (8) . High plasma glucose levels are associated with increased hepatic glycolytic rates and elevated levels of mitochondrial citrate. Fatty acid biosynthesis is initiated by citrate transporter protein (CTP) transport of citrate from the mitochondria to the cytosol (Fig. 1, A and B) . Acetyl-CoA, a product of ATP citrate lyase, is then converted to malonyl-CoA by acetyl-CoA carboxylase, and malonyl-CoA is used as a precursor for fatty acid synthesis via fatty acid synthase. In addition to the role in de novo fatty acid synthesis, malonyl-CoA also serves as a key regulator of fatty acid oxidation through allosteric inhibition of the mitochondrial fatty acid transporter carnitine palmitoyl-transferase 1a (CPT1a) (8, 9) . This regulation ensures that fatty acids are excluded from the mitochondria when malonyl-CoA level is high. Conversely, fatty acid oxidation proceeds when glucose, and thus malonyl-CoA levels, are decreased. Fatty acid oxidation occurs in the mitochondria to generate acetyl-CoA and reducing equivalents ( Fig. 1 C) .
We have previously shown that liver-specific expression of the nonnative two-enzyme glyoxylate pathway, isocitrate lyase (ACEA) and malate synthase (ACEB), increases fatty acid oxidation and confers resistance to diet-induced obesity in C57BL/6 mice (10) . This pathway creates an additional channel for fatty acid oxidation and decreases malonyl-CoA levels, a fatty acid oxidation inhibitor. Additionally, mice expressing the glyoxylate shunt in the liver accumulate significantly less fat mass on a high fat diet than the control mice and exhibit decreased plasma triglyceride levels. A human hepatocyte HepG2 cell line expressing the glyoxylate shunt (designated ACE) was also found to have increased fatty acid degradation and decreased glucose uptake compared to wild-type (WT) cells (Fig. 2, A and B) . Based on pathway stoichiometry, the resulting phenotype from glyoxylate shunt expression cannot be predicted: it may increase, decrease, or have no effect on fatty acid degradation depending on how the pathway integrates into the native metabolic and regulatory networks. The first possibility is that carbon conserved from the glyoxylate shunt may be incorporated into mitochondrial citrate, and transported out of the mitochondria for fatty acid synthesis.
This cycle results in malonyl-CoA production and is expected to inhibit fatty acid degradation. The second possibility is that the tricarboxylic acid cycle (TCA) cycle inter-mediates can be conserved by the glyoxylate shunt and used as gluconeogenesis substrate. This route is used by plants and bacteria for growth with fatty acids as the carbon source. Alternatively, an option exists where the conserved carbon is shuttled out of the mitochondria as malate and oxidized to pyruvate through cytosolic malic enzyme (ME1). These enzymes form an additional cycle for acetyl CoA oxidation (11, 12) .
The general aim of this study is to further investigate the effect of hepatic glyoxylate shunt expression and gain further insight into hepatic fatty acid metabolism, and for this purpose we used a mathematical approach termed ensemble modeling (EM) (13) . Predicting the effect of perturbations such as an overexpression or knockdown on a metabolic network is often nontrivial because of interconnected enzymatic reactions, cofactor balancing, and regulations (12, (14) (15) (16) (17) . Mathematical analysis has proven to be a useful tool in the study of metabolic networks (12, (18) (19) (20) (21) (22) and liver metabolism (23) (24) (25) (26) . The modeling approach allows for greater understanding of metabolism and may ultimately serve as a platform for predicting genotype-phenotype relationships and targets for driving metabolism to a desired state, or in this case, targets for obesity management.
In EM, the enzymatic reactions of the metabolic network are formulated as elementary reactions and parameters are sampled under the thermodynamic and steady-state constraints. As data available are insufficient to define kinetic parameters uniquely, all parameter sets that describe the available data are retained in the ensemble and screened with available data. Each parameter set is called a model. By introducing a perturbation to the metabolic network and determining the resulting behavior, we are able to screen the models according to previously determined experimental data or make predictions for future experimental tests under the known mechanistic framework.
In this work, we ask the question: is the current metabolic mechanism sufficient to explain the phenotype (increased fatty acid degradation and decreased glucose consumption) and if so, is there any particular range of parameters suitable to explain the phenotype? As we do not have kinetic parameters, nor do we have data in the transient state, our models are constrained by the only known data, steady-state fluxes for the reference state (control cells). EM allows us to create an ensemble of models that essentially span all kinetic space based on the currently known metabolic mechanism but are constrained to the same known steady state. It should be noted that the steady state of the perturbation (engineered cells) depends on kinetic parameters in the reference (control) cells. Thus, the steady-state phenotype after perturbation can be used to screen for allowable or exclude unallowable parameter regions. The allowable parameter regions explain the phenotype based on current mechanisms, and provide the hypotheses to be tested further.
Interestingly, we show that the currently available mechanisms do not readily explain the observed increased fatty acid degradation and decreased glucose consumption in ACE cells, regardless of extensive parameters sampled. This result prompted us to investigate regulation of glucose metabolism by metabolites related to glyoxylate shunt. Indeed, we found that malate decreased hexokinase 2 (HK2) expression using reverse transcription-polymerase chain reaction (RT-PCR). By incorporating this novel observation, we show that some of the models in the ensemble were able to describe the observed perturbation phenotypes. However, the success of the model depends on the two split ratios in two branched points. If these parameters are far from the allowable region, the currently available mechanism with the malate-HK2 regulation cannot explain the observed phenotype after glyoxylate shunt introduction. These split ratio ranges, although fuzzy, constitute a new hypothesis for further investigation.
MATERIALS AND METHODS

Stable cell line generation and cell culture
Human hepatoma cell line, HepG2 (American Type Culture Collection, Manassas, VA), was maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 50 mg/mL penicillin, 50 mg/mL streptomycin, and 100 mg/mL neomycin at 37 C in a humidified atmosphere containing 5% CO 2 . Cells were stably transfected with a pBudACEAB (10), a vector containing ACEA and ACEB fused to mitochondrial leader sequences, as previously described (10) .
Metabolite quantification
Metabolites were quantified as previously described (10) . In brief, 16 h before uptake assays, cells were seeded 1.75 Â 10 5 cells/well in 24-well multi-plates containing DMEM supplemented with 10% FBS. Cells were washed with phosphate-buffered saline (PBS) and then incubated in 1.5 mL of DMEM media enriched with 300 mM palmitate and 25 mM glucose, and media samples were collected after 4 h. After incubation, metabolites were quantified and total protein was assayed by the method of Bradford (27) .
Reverse-transcriptase polymerase chain reaction (RT-PCR)
Sixteen hours before reverse transcription-polymerase chain reaction (RT-PCR) assay, 2.5 Â 10 6 cells were plated in 60-mM plates. For HK2 expression studies, cells were washed 3Â with PBS and cells were incubated in DMEM containing 10% FBS and various concentrations of either malate or succinate for 3.5 h. It has previously been shown that TCA cycle intermediates, including malate (28, 29) and succinate (30) , are readily transported intracellularly. After incubation, cells were washed 3Â with PBS, and RNA was isolated using RNeasy columns (Qiagen, Valencia, CA). First-strand 
Overview of ensemble modeling (EM)
Complete modeling of metabolic networks requires full sets of kinetic parameters and experimental data for validation. As we do not have kinetic parameters and the available data are too scarce to estimate parameters in a meaningful way, we used EM to examine the consistency between the known mechanisms and experimental data. The goal of EM is to develop a set of kinetic models with the same structure but different kinetic parameters such that these models (with different parameters) all reach the same steady state (13, 32, 33) . If the general model is described as the following set of nonlinear ordinary differential equations,
where v i and v j are the enzyme kinetic functions (i, production, j, consumption of species x i ), then the problem can be stated mathematically as determining or sampling all the kinetic parameters k, such that
where n ref net is the net steady-state flux (known) for each enzyme in the reference cell, and x ss is the steady-state concentration of the metabolite species. The major difficulty of this problem is that the constrained sampling of k to satisfy Eq. 2 is time-consuming for general nonlinear functions. EM circumvents such a hurdle by using elementary reaction schemes, which are the most fundamental description of enzyme kinetics and follow mass-action kinetics. The log-linear property of mass-action kinetics provides us a platform for efficient constrained sampling of k and network scale-up. As the elementary reactions are all thermodynamically reversible, details of handling unidirectional fluxes will be described shortly.
This ensemble of models represents all possible kinetics given the same steady-state flux and kinetic mechanisms. Once the initial ensemble of models is constructed, each one of them is perturbed the same way as in the experiments. In this case, the glyoxylate shunt enzymes in the model are elevated in the model, as in the experiment. One then re-solves the ordinary differential equations using the same parameter sets, but with overexpressed glyoxylate shunt enzymes. The models that predict the experimental data (increased fatty acid degradation and decreased glucose consumption flux) after the glyoxylate shunt expression are retained. The process can be repeated when more data are available. Note that this strategy does not aim at estimating the best-fit parameters, because of the scarcity of data. Instead, it examines the possible matching between models with currently known mechanisms and experimental data.
Determination of steady-state reference flux
A network consisting of 85 metabolites and 85 reactions was used to model hepatic metabolism (see Fig. 1 , A-C; Tables 1-3; Table S1, Table S2 , Table S3 , Table S4 , and Table S5 in the Supporting Material). Metabolite concentration data for glucose uptake, lactate production, and fatty acid uptake was used to determine the steady-state internal flux distribution (Fig. 2, A and B) . Steady-state fluxes were calculated by setting Eq. 1 to zero. To solve for remaining degrees of freedom, we varied the split ratio of citrate transporter protein (CTP)/citrate synthase (CS) and pyruvate carboxylase (PC)/pyruvate mitochondrial transporter (PYRT) and solved for the internal fluxes. Because Eq. 1 has no solution for certain combinations of these two split ratios, the upper and lower boundaries of allowable split ratios were first identified ( Fig. 2 C) . Once the boundaries of allowable split ratios were determined, external metabolite production data was combined with various split ratios and Eq. 1 was solved for within the allowable split-ratio subset area. When solving for internal steady-state reference fluxes, flux through the glyoxylate shunt was initially set to~2% of the measured glucose uptake because hepatocytes have previously been shown to have low glyoxylate shunt activity under certain conditions (34, 35) . Even though these intrinsic activities are still debatable, 2% flux does not change the conclusion and accounts for possible intrinsic glyoxylate shunt activities reported previously (31, 32) . Constructing an ensemble of models
As stated above, EM models enzymatic reactions as basic elementary reactions that follow mass-action kinetics. The conversion of metabolite i to iþ1 by enzyme E i is
This can be described in terms of six elementary reactions as
Step 2
Step 3
where each elementary reaction follows mass-action kinetics,
and where k i,1 is the rate constant of the forward reaction of step 1 of the overall reaction catalyzed by the enzyme E i , [X i ] is the concentration of metabolite i, and [E i ] is the concentration of free enzyme i (Table S6) 
where n ref i;2jÀ1 and n ref i;2j represent the forward and reverse reactions of step j catalyzed by enzyme i, and the difference is the net flux determined previously. The reversibility is then defined as (13) 
where R i,j ¼ 0 for irreversible steps and 1 for a step at equilibrium. For the overall reaction catalyzed by enzyme i, the reversibilities are constrained by the Gibbs free energy,
where n i represents the number of elementary reactions for the overall reaction catalyzed by enzyme i and a reaction with a positive (forward) net flux has sign(V i,net ) ¼ þ1 and a reaction with a negative net flux (reverse) has a value of À1. Equation 9 ensures that the net flux for reaction i will be positive if DG i < 0, but that the net flux will be negative if DG i > 0. The exact values for Gibb's free energies cannot be calculated because they are a function of metabolite concentrations; therefore, we calculate a range of reversibilities by allowing metabolite concentrations to vary within a 100-fold change range. This yields a range of Gibbs free energies:
Additionally, the fractions of bound and free forms of enzyme i are sampled such that their sum is equal to 1. There are many combinations of reversibilities and enzyme fractions for each reference state. Once the reversibilities and enzyme fractions are sampled, kinetic parameters are solved for from the normalized version of Eq. 5. Each model thus contains kinetic parameters that are defined from the reversibilities and enzyme fractions that were sampled for that particular model and the entire ensemble of models reach the same steady state as defined by the reference state. To study the effects of glyoxylate shunt expression, ACEA and ACEB enzyme concentrations were increased 10-fold.
Screening of models by Michaelis-Menten constant K m
In an effort to generate and retain models with physiologically relevant kinetic parameters, we implemented an additional step to screen models for experimentally determined K m values. Initially, an ensemble of 1 Â 10 6 models were created for each reference state as described in Eqs. 1-10. A K m value for the elementary reactions shown in Eq. 4 has been previously derived (15) as
Models matching experimentally determined K m values (with 25% tolerance) for glucose-6-phosphate isomerase (GPI, K m ¼ 0.445 mM), phosphoglyceratemutase (PGAM, K m ¼ 0.22 mM), enolase (ENO, K m ¼ 0.30 mM), and aconitase1 (ACO1, K m ¼ 0.30 mM) were retained and used for analyzing the effect of glyoxylate shunt overexpression.
RESULTS
The hepatocyte fatty acid metabolic network
A human HepG2 cell line was used in the study. The hepatic metabolic network, shown in Fig. 1 , A-C, contains 85 metabolites and 85 reactions and includes glycolysis, TCA cycle, fatty acid synthesis and degradation, anaplerotic reactions, and compartmentalized ATP and cofactors. Tables 1  and 2 contain a full description of all abbreviations used. As flux through the pentose pathway has been shown to be <5% of glucose uptake flux for the HepG2 cell line, it was excluded from this model (36) . Triglycerides and ketone body formations were shown to be unchanged in the cell cultures with or without the glyoxylate shunt expression. Thus, these pathways were not included in the model. Additionally, allosteric regulation of PFK (37), PDH (38) , and CPT1a (9) enzymes was incorporated into the model (Table 3 ). Allosteric regulation was incorporated into the models as mixed inhibition, which includes both competitive and uncompetitive inhibition ( Table 4 ). Competitive inhibition refers to the case when inhibitor-enzyme binding prevents substrate binding and uncompetitive inhibition occurs when the inhibitor metabolite only binds to the enzymesubstrate complex. The human HepG2 cell line transfected with the control gene (lacZ) was used as the reference state. The reference states were generated through measurement of WT glucose uptake, lactate production, and fatty acid uptake (Fig. 2, A  and B) . The glyoxylate shunt flux was assigned to 2% of glucose flux, as WT cells were found to have low basal glyoxylate shunt enzyme activity (10) . The remaining degrees of freedom were examined by varying the CTP/CS and PC/PYRT split ratios. These split ratios define the space within which we examine the effect of introducing the glyoxylate shunt genes into the cell. As solutions for the steady state were unachievable for certain combinations of split ratios (Eq. 1), the upper limits and boundaries of allowable split ratios were first identified. Unachievable split ratio combinations are shown in the open region in Fig. 2 C, whereas achievable combinations are shown in the shaded region. Once the boundaries for achievable split ratios were identified, 25 sets of reference steady-state fluxes were generated based on external metabolite measurements and the split ratio of interest. Reference states were chosen with split ratio combinations from the border of the allowable split ratio area as well as with split ratio combinations from within the allowable area.
Screening of models based on experimentally determined kinetic parameters
The reference state reactions were formulated as elementary reactions (Eqs. 3-5) and reversibilities and enzyme fractions were sampled for each reference state (Eqs. 6-10), thus producing an ensemble of models for each reference state within the allowable split ratio area. For this analysis, 10 6 models were initially generated for each reference state. After ensuring that the reversibilities were thermodynamically compliant (Eqs. 9 and 10), kinetic parameters for the elementary reactions were calculated for the models within the ensemble for each reference state. The elementary reaction kinetics can then be used to calculate the Michaelis-Menten constant (K m ). In an effort to retain models with physiological relevance, we screened the 1 Â 10 6 generated models for those with experimentally determined K m values. Specifically, models matching experimentally determined K m values for glucose-6-phosphate isomerase (GPI), phosphoglyceratemutase (PGAM), enolase (ENO), and aconi-tase1 (ACO1) were retained and used to analyze the effects of glyoxylate shunt expression (discussed in detail below; see Eq. 11). Typically~150 models were retained out of the initial 10 6 models screened. This process allowed us to generate an ensemble of~150 models for each reference state within the allowable split ratio subset area.
Malate inhibits HK2 expression
To study the effect of glyoxylate shunt expression, the enzyme concentrations of ACEA and ACEB were increased 10-fold and the new steady-state fluxes of each model within each ensemble for each reference state were solved. Unfortunately, even after screening for the K m values, the 
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resulting models could not describe the phenotype observed (increased fatty acid degradation and decreased glucose consumption) after introducing the glyoxylate shunt enzymes. Even though we have not proven mathematically that no feasible set of parameters exist to describe these data, the initial negative result prompted us to look for novel metabolic regulation that is not accounted for in the literature.
In an attempt to further understand the decreased glucose uptake in ACE cells we tested candidate signaling metabolites for effects on gene expression. Cells were incubated in medium containing various concentrations of candidate molecules for 3.5 h, after which RNA was harvested and gene expression changes were determined by RT-PCR.
We found that addition of malate to the cell medium decreased HK2 gene expression ( Fig. 2 D) . We also tested the effects of other TCA metabolites on HK2 expression and found a markedly smaller effect than that of malate on HK2 expression. This demonstrates that although other metabolites may influence gene expression, malate's effect is most pronounced. As we do not know the detailed mechanism of this regulation and as our model does not account for gene expression changes at this time, we represented the malate inhibition as allosteric enzyme regulation (Table 4 ). This regulation is then incorporated in the following studies.
The effect of ACEA and ACEB expression
With the above malate-HK2 regulation in the models and sampled kinetic parameters, the enzyme concentrations of ACEA and ACEB were increased 10-fold and the new steady-state fluxes of each model within each ensemble for each reference state were solved. The predicted steady-state flux for each reference state after ACEA and ACEB perturbation was calculated as the average predicted steady-state flux of all 150 models and a plot was generated for fluxes using triangle-based linear interpolation (39) . We found the effect of glyoxylate shunt expression was a function of the reference state PC/PYRT and CTP/CS split ratios (Fig. 3 , A-C). Specifically, we found that reference states with low CTP/CS split ratios (<0.1) predicted no change in fatty acid uptake after glyoxylate shunt expression ( Fig. 3 A) . Conversely, reference states with PC/PYRT split ratios between 0.3 and 0.7 and maximum allowable CTP/CS split ratios, 0.2-0.5, predicted increases in fatty acid uptake after glyoxylate shunt expression. The maximum predicted FIGURE 3 EM was used to investigate the dependence of glyoxylate shunt expression on reference state for (A) fatty acid uptake, (B) glucose uptake, and (C) lactate production. A subset of split ratios predicted increased fatty acid uptake and decreased glucose uptake after glyoxylate shunt expression, consistent with experimental data, whereas others predicted no change. Open areas represent split ratio areas where reference steady state was unsolvable according to Eq. 1. (D) The predicted change in CPT1a flux is dependent on the initial reference state. The predicted changes in CPT1a and fatty acid uptake were proportional. (E) ME1 expression as a function of reference state. Our previous analysis implicated ME1 in a cycle for oxidation of acetyl-CoA. The predicted glucose uptake after glyoxylate shunt expression was inversely related to the predicted change in ME1: a predicted increase in ME1 expression meant a predicted decrease in glucose uptake. (F) ME1 flux % change as a function of glucose uptake % change for 148 models. Individual model results are shown as blue triangles, whereas the average for the ensemble is represented as a red square.
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Ensemble Modeling of Hepatic Glyoxylate Shunt Expression increase, 58%, in fatty acid uptake occurred at a PC/PYRT of 0.5 and CTP/CS split ratio of 0.29. This predicted increase was close to the 70% increase determined experimentally (Fig. 2 B) .
EM was also used to examine the effect of ACEA and ACEB expression on glucose uptake (Fig. 3 B) . Similar to fatty acid uptake, we found that the effect of glyoxylate shunt expression on glucose uptake was dependent on the initial reference state and that multiple possibilities exist. Using EM we found that a PC/PYRT split ratio region between 0.5 and 0.8 and CTP/CS split ratio between 0 and 0.2 predicted no change or an increase in glucose uptake after glyoxylate shunt expression ( Fig. 3 B) . Interestingly, the region which showed no change or an increase in glucose uptake also showed no change in fatty acid uptake ( Fig. 3  A) . As the CTP/CS split ratio was increased, a decrease in glucose uptake was predicted. Low (<0.1) PC/PYRT and CTP/CS split ratio reference states were found to predict >60% decrease in glucose uptake, a much greater decrease than what was found experimentally (47% decrease, Fig. 2  B) . The split ratio region (PC/PYRT: 0.5, CTP/CS: 0.29), which predicted the highest and most accurate increase in fatty acid uptake ( Fig. 3 A) , showed a 40% decrease in glucose uptake after glyoxylate shunt expression ( Fig. 3  B) , which was also a close match to the experimentally determined value of 47% decrease (Fig. 2 B) We also looked at the effect of glyoxylate shunt expression on lactate production ( Fig. 3 C) . As previously documented (10), lactate production was found to be proportional to glucose uptake and a surface plot demonstrated that a predicted decrease in lactate production was congruous with a predicted decrease in glucose uptake, and vice versa.
The effect of glyoxylate shunt perturbation on internal fluxes CPT1a and ME1
We next examined the effect of glyoxylate shunt expression on the internal fluxes CPT1a (Fig. 3 D) and cytosolic malic enzyme (ME1) (Fig. 3 E) . As expected based on analysis of external uptake fluxes (Fig. 3, A-C) , the change in these fluxes was found to be dependent on the initial reference state. We found that reference states that predicted increases in fatty acid uptake also predicted increases in CPT1a flux ( Fig. 3 D) . As stated above, reference states with low CTP/CS split ratios predicted no change in fatty acid uptake after perturbation, and a similar trend was found when examining CPT1a. Interestingly, the reference state with the highest predicted increase in CPT1a flux (PC/PYRT: 0.1, CTP/CS: 0.1) was not the reference state with highest predicted increase in fatty acid uptake. This can possibly be explained by the fact that this reference state also predicted an increase in ACC flux, suggesting glyoxylate shunt perturbation of this reference state generates a futile cycle where fatty acids are concurrently synthesized and oxidized.
As we have previously shown that ACE cells use the glyoxylate shunt and ME1 as an alternate cycle for complete oxidation of acetyl-CoA to CO 2 (10) , we used EM to analyze the effect of glyoxylate shunt expression on ME1 flux. We found that the predicted change in ME1 flux was inversely proportional to glucose uptake (Fig. 3 , E and F): reference states predicting increases in ME1 expression predicted decreases in glucose uptake. Similarly, we found that reference states predicting increases in fatty acid uptake after glyoxylate shunt perturbation predicted increases in ME1 expression. This trend was also found to be consistent at the level of the individual model ( Fig. 3 F) . This analysis demonstrates that ME1 flux is an integral component of the phenotype generated by glyoxylate shunt expression.
Importance of malate-HK2 regulation
As discussed above, the malate-HK2 regulation (Fig. 2 D) was essential in describing the observed phenotypes. This suggests that the glyoxylate shunt may decrease glucose uptake by generating additional malate through increased ME1 flux. This is also seen in Fig. 3 , E and F, where glucose uptake was found to be inversely proportional to ME1 flux. To test the hypothesis that ME1 flux and malate concentrations inhibit glucose uptake we removed the allosteric inhibition of HK2 by malate and analyzed the effects of FIGURE 4 Malate inhibition of HK2 must be included in model to accurately predict ACE phenotype. Experimental data and EM prediction with and without malate inhibition of HK2 for (A) fatty acid uptake, (B) glucose uptake, and (C) lactate production.
Biophysical Journal 98(8) 1385-1395 glyoxylate shunt perturbation on extracellular uptake fluxes. For this analysis we choose to use the reference state (PC/PYRT: 0.5, CTP/CS: 0.29), which was previously found to predict the most accurate increase in fatty acid and decrease in glucose uptake after glyoxylate shunt expression. Interestingly, we found that EM more accurately captures the increased fatty acid uptake observed in ACE cells when this regulation is included in the model (Fig. 4 A) .
After perturbing the glyoxylate shunt in this reference state with Malate-HK2 regulation removed we did not find a predicted decrease in glucose uptake (Fig. 4 B) or in lactate production ( Fig. 4 C) . Taken together, this analysis shows that both the flux through ME1 and the regulatory properties of malate may be necessary for the ACE phenotype.
Importance of screening the ensemble of models by K m
To retain models with physiologically relevant kinetic parameters, we screened the models of each ensemble for those with K m values matching experimentally determined values. Models matching experimentally determined K m values (40) for glucose-6-phosphate isomerase (GPI, K m ¼ 0.445 mM), phosphoglyceratemutase (PGAM, K m ¼ 0.22 mM), enolase (ENO, K m ¼ 0.30 mM), and aconitase1 (ACO1, K m ¼ 0.30 mM) were retained and used to investigate the effects of glyoxylate shunt perturbation. Initially, 10 6 models were generated for each reference state and models with desired K m values, typically~150, were retained for further analysis (Fig. 5 A) . To test whether this screening step improved the capacity of EM to quantitatively predict phenotypes we analyzed the effects of glyoxylate shunt expression by perturbing 148 models (PC/PYRT: 0.5, CTP/CS: 0.29) that had not been screen according to physiologically relevant K m values. We found that omitting this K m screening step resulted in a predicted fatty acid uptake rate that was not as accurate as when the K m screening was used ( Fig. 5 B) . Additionally, a two-sample Kolmogorov-Smirnov test (41) demonstrated that distribution of fatty acid uptake rates between ensembles that were perturbed with and without K m screening was significantly different with >95% confidence (p-value ¼ 0.0145). These results indicate that the screening based on known kinetic parameters did improve the model, and that more experimentally determined kinetic parameters will further improve the model.
DISCUSSION
We have previously shown that hepatic glyoxylate shunt expression increases fatty acid oxidation both in vitro and in vivo. This nonnative pathway provides an additional channel for acetyl-CoA oxidation and decreases malonyl-CoA levels in the liver. Inspecting the pathway stoichiometry showed that the outcome of glyoxylate shunt expression cannot be intuitively predicted: it may lead to an increase, decrease, or no change in fatty acid degradation based on how the pathway integrates into the host metabolic structure. In this work we use EM to further investigate the effect of hepatic glyoxylate shunt expression. We found that current Fatty Acid Uptake % Increase FIGURE 5 The ensemble of models were screened according to experimentally verified K m values. (A) 1 Â 10 6 models were initially generated as described in Materials and Methods and models with physiologically relevant kinetic parameters were retained. Approximately 150 models were typically retained. (B) Screening by K m results in a more quantitatively accurate prediction of fatty acid uptake. The term ''EM, ÀK m screen'' refers to EM prediction without any K m model screening, whereas the ''EM, þK m '' screen refers to EM prediction with models screened according to relevant K m parameters, as described in Screening of Models by Michaelis-Menten Constant K m . (C) The distribution of fatty acid uptake rates between ensembles that were perturbed with and without K m screening was significantly different with >95% confidence (p-value ¼ 0.0145).
Ensemble Modeling of Hepatic Glyoxylate Shunt Expression mechanisms of glucose and fatty acid metabolism were not able to describe the observed phenotypes even qualitatively, despite exhaustive sampling of kinetic parameters. This finding led us to the discovery that addition of malate to the extracellular cell medium decreased HK2 gene expression. By including this regulation in EM's regulatory network we were able to describe the decrease in glucose uptake observed in ACE cells. We further showed that the predicted change in extracellular and intracellular fluxes was a function of reference state PC/PYRT and CTP/CS split ratios. Specifically, we found that reference states with low (<0.1) CTP/CS split ratios predict no change in either fatty acid or glucose uptake. Conversely, a reference state was identified (PC/PYRT: 0.5, CTP/CS: 0.29) which predicted a 58% increase in fatty acid uptake, closely matching the 70% measured experimentally. This reference state also predicted a 40% decrease in glucose uptake after glyoxylate shunt perturbation, which is accurate when compared to the 47% decrease observed experimentally. Examining the change in internal fluxes after glyoxylate shunt perturbation showed that increased ME1 flux was necessary for the increased fatty acid uptake observed in ACE cells. This result was also supported by an RNA i knockdown experiment (10) . The increase in ME1 flux was inversely proportional to glucose uptake. This finding explains the importance of the malate-HK2 regulation. When ME1 flux increases, malate concentration presumably increases, which reduces HK2 gene expression. By including this regulation in EM's regulatory network we were able to describe the decrease in glucose uptake observed in ACE cells. Additionally, in this work we show that screening the ensemble of models by experimentally determined K m values improves the predictive capacity.
This work demonstrates that EM is a suitable tool for studying metabolic perturbations by enzyme expression tuning, such as gene overexpression, RNAi knockdown, or introducing a synthetic pathway (42) . The effect of these manipulations depends on the physiological context, namely the kinetic parameters for other enzymes in the network. As these parameters are never completely available, a framework dealing with unknown parameters by sampling is necessary. Previously, Wang et al. (18) developed a method for performing metabolic control analysis under uncertainty. This work allows the examination of small changes of enzymes, as the analysis is based on linearization of models. EM uses a full mechanistic model without linearization, and allows the investigation of any changes in the system. By extensive sampling of parameters in all allowable ranges, the investigator can examine whether the current mechanism is sufficient to describe the available data. The EM can also predict the behavior for future perturbations, thus generating hypotheses for testing. The disadvantage of EM, however, resides in the large parameter space and the relatively long computation time (hours to days on personal computers). The limitation of EM can be overcome by further improve-ment of EM algorithms and by using the ever-increasing computing capability.
